"Telehealth, which includes mobile health (mHealth) technology, is the future of medicine," said Lynn Webster, MD, in a recent discussion with Patient Care Online. Dr Webster is the chief medical officer of PainScript™, a medical technology company that has a unqiue mHealth platform that allows clinicians to interact with their patients with chronic pain on a daily basis via smartphone.
"The PainScript platform is innovative in its focus on physician practice management, providing a patient-monitoring capability to support adherence with treatments (pharmacologic and nonpharmacologic) and provide early detection of adverse/serious adverse events," wrote Dr Webster and colleagues in a recent large observational trial, which Dr Webster presented at PAINWeek 2022.
In the video below, Dr Webster talks about his background in chronic pain, provides a quick primer on the PainScript mHealth platform, and highlights key findings from the analysis that may be of interest to clinicians.
Cebranopadol Achieves Positive Phase 3 Results for Treatment of Moderate-to-Severe Acute Pain
January 22nd 2025Cebranopadol, an investigational oral dual-NMR agonist, satisfied the primary endpoint of statistically significant reduction in pain intensity compared to placebo following abdominoplasty surgery.